Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Charles K. Anderson
Willamette Valley Cancer Institute and Research Center
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
101
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Avelumab Alone or in Combination with Chemotherapy vs Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): A Randomised, Open-Label, Phase 3 Study
Number of pages: 52
Posted: 28 Oct 2020
Eric Pujade-Lauraine
,
Keiichi Fujiwara
,
Jonathan A. Ledermann
,
Amit M. Oza
,
Rebecca S. Kristeleit
,
Isabelle-Laure Ray-Coquard
,
Gary E. Richardson
,
Cristiana Sessa
,
Kan Yonemori
,
Susana Banerjee
,
Alexandra Leary
,
Anna V. Tinker
,
Kyung Hae Jung
,
Radoslaw Madry
,
Sang-Yoon Park
,
Sang-Yoon Park
, Charles K. Anderson,
Fabian Zohren
,
Ross A. Stewart
,
Caimiao Wei
,
Samuel S. Dychter
and
Bradley J. Monk
ARCAGY-GINECO, Saitama Medical University International Medical Center (SIMC), University College London - UCL Cancer Institute, University of Toronto - Princess Margaret Cancer Centre, University College London - UCL Cancer Institute, University of Claude Bernard Lyon 1 - Medical Oncology Department, Cabrini Hospital - Department of Medical Oncology, Ospedale San Giovanni - Oncology Institute of Southern Switzerland (IOSI), National Cancer Center Hospital - Department of Breast and Medical Oncology, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Université Paris XI Sud - Gustave Roussy Cancer Campus, BC Cancer, University of Ulsan - Department of Oncology, Poznan University of Medical Sciences - Department of Oncology, National Cancer Center - Center for Uterine CancerNational Cancer Center, Korea - Center for Gynecologic Cancer, Willamette Valley Cancer Institute and Research Center, Pfizer Oncology, Pfizer Oncology, Pfizer, Inc. - Pfizer Global Biometrics and Data Management, Pfizer Oncology and University of Arizona - College of Medicine, Arizona Oncology (US Oncology Network)
Downloads
101
(684,672)
View PDF
Download
Abstract:
ovarian cancer, Avelumab, PD-L1, Phase 3, immune checkpoint inhibitor
Feedback